September 12, 2025

Organ Donation: Where Do We Draw the Line?

A case highlights challenges in brain death determination and organ donation practices.

KFF Health News

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 12, 2025

Researcher is awarded grant from BrightFocus Foundation’s National Glaucoma Research Program

UCI researcher receives BrightFocus funding to explore how eye pressure and aging impact vision loss.

UCI Health

September 12, 2025

UCI Health cardiologist is American Heart Association's Woman of Impact

Shaista Malik, MD, PhD, MPH receives the AHA Woman of Impact award for advancing cardiovascular care and awareness for women.

UCI Health

September 12, 2025

Hearing Loss May Lower Employment and Income Odds

National cohort data showed hearing loss tied to reduced work participation and pay with certain demographics impacted more than others.

Conexiant

September 12, 2025

Hypofractionated Radiotherapy Plus Concurrent Chemotherapy vs Conventional Radiotherapy in Phase III Trial for LS-SCLC

A reduced schedule for hypofractionated radiotherapy with concurrent chemotherapy led to numerically similar survival outcomes and a more favorable safety profile than a standard course of conventiona...

The ASCO Post

September 12, 2025

Tarlatamab and Anti–PD-1 Therapy as First-Line Maintenance for ES-SCLC

The DLL3-targeted bispecific T-cell engager agent tarlatamab demonstrated significant overall survival in combination with anti‒PD-L1 therapy of either atezolizumab or durvalumab as first-line mainten...

The ASCO Post

September 12, 2025

What Keeps Suicidal Teens Alive?

Corpus review shows suicidal adolescents most often cite family and friends; future aspirations also appear frequently.

Conexiant

September 12, 2025

Cemiplimab Reduces Recurrence in High-Risk cSCC

First adjuvant immunotherapy trial shows 23% absolute reduction in recurrence for resected cutaneous squamous cell carcinoma.

Conexiant